Hunan Warrant Pharmaceutical Co., Ltd., established in 2001 and listed on the Shanghai Stock Exchange STAR Market in 2021, is a leading innovation-driven pharmaceutical manufacturer headquartered in Changsha, China. The company operates a comprehensive industrial chain that integrates R&D, production, and sales across chemical medicines, traditional Chinese medicine (TCM), and biological macromolecules. With a workforce of over 1,000 employees and an annual revenue reaching approximately CNY 950 million, the company maintains three GMP-certified manufacturing factories and three specialized R&D institutes. Hunan Warrant Pharmaceutical specializes in a diverse portfolio including Active Pharmaceutical Ingredients (APIs), pharmaceutical excipients, intermediates, and finished drug preparations. Key API products include Mycophenolate Mofetil, Fosfomycin Trometamol, Entecavir, Ticagrelor, and Pantoprazole Sodium. Their herbal extract division focuses on high-purity standardized production of Ivy Leaf, Green Tea, and Ginkgo Biloba extracts, serving the health products, cosmetics, and feed additive industries. As a vertically integrated provider, the company offers OEM, ODM, and contract manufacturing (CMO/CRO) services. Their commitment to quality is evidenced by GMP certifications and drug production licenses (DML), supporting their competitive presence in both domestic and international pharmaceutical markets.
Hunan Er-Kang Pharmaceutical Co., Ltd. is a leading public pharmaceutical enterprise based in Changsha, China, recognized as the nation's largest-scale manufacturer of pharmaceutical excipients. Founded in 2003, the company operates a state-level R&D center and maintains a workforce of over 1,400 employees. It specializes in the research, development, and production of a comprehensive range of pharmaceutical products, including excipients, active pharmaceutical ingredients (APIs), and finished drugs. The company is a global pioneer in starch-based technology, operating the world's largest Starch Capsule Industrial Park with an annual capacity of 120 billion capsules. Their innovative product line features the world's first Hydroxypropyl Starch Capsule, a non-animal origin solution certified by the Vegetarian Society and registered with the FDA. Core product offerings include over 120 conventional excipients such as medicinal glycerin, ethanol, and propylene glycol, alongside APIs like sulbenicillin sodium, caffeine, and folic acid. The company also produces plant extracts, organic cassava starch, and finished drugs such as compound liquorice tablets. With more than 10 production lines and a strong commitment to international quality standards, Hunan Er-Kang Pharmaceutical holds ISO, HALAL, Kosher, CE, and FDA certifications. The company serves over 4,000 pharmaceutical enterprises worldwide and offers extensive OEM and contract manufacturing services, including specialized plant-derived softgel solutions and health-related products like hand sanitizers.
1000ml Gel Hand Sanitizer Ce$2
OEM 100ml Hand Sanitizer Anticovid19 Disinfect Sterilization$0.48
OEM 60ml Hand Sanitizer Anticovid19 Disinfect Sterilization$0.32